Japanese Drug Store Chain Growell Launches Takeover Bid For Terashima
This article was originally published in PharmAsia News
Japanese drug store chain Growell Holdings launches a takeover bid for Terashima, a Tsukuba-based drug store chain with around 100 stores. Growell plans to acquire 50.18 percent of Terashima's outstanding shares and take the company as a subsidiary after the deal. Terashima President Takao Terashima was approached by Growell and the two sides started negotiations in August. Growell was established by a merger of Welcia Kanto and Takada Yakyoku. Japanese retailer Aeon Group is the largest share holder of both Growell and Terashima. (Click here for more - Japanese language
You may also be interested in...
The US HHS played defense on 20 September, pushing back on suggestions that secretary Alex Azar’s recent move to exert control over regulations by signing off on them was a power play aimed at the FDA. Meanwhile, former agency head Scott Gottlieb says it’s “the wrong move at the wrong time.”
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?
Lorbrena is approved as a second-line treatment for ALK-positive NSCLC but Pfizer believes data from the first-line Phase III CROWN study makes the drug a serious competitor to standard of care Alecensa in the first-line setting.